- Home
- RNA vs DRS Comparison
RNA vs DRS Comparison
Compare RNA & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | DRS |
|---|---|---|
| Founded | 2012 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 8.8B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RNA | DRS |
|---|---|---|
| Price | $72.90 | $38.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 6 |
| Target Price | ★ $69.26 | $46.83 |
| AVG Volume (30 Days) | ★ 2.1M | 984.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | 0.69 | ★ 25.00 |
| EPS | N/A | ★ 0.65 |
| Revenue | $10,897,000.00 | ★ $3,234,000,000.00 |
| Revenue This Year | $88.12 | $11.90 |
| Revenue Next Year | $18.11 | $6.69 |
| P/E Ratio | ★ N/A | $61.58 |
| Revenue Growth | 13.99 | ★ 14.44 |
| 52 Week Low | $25.28 | $28.17 |
| 52 Week High | $73.06 | $49.31 |
Technical Indicators
Market Signals| Indicator | RNA | DRS |
|---|---|---|
| Relative Strength Index (RSI) | 64.95 | 45.92 |
| Support Level | $70.42 | $37.08 |
| Resistance Level | $73.04 | $42.82 |
| Average True Range (ATR) | 0.21 | 1.68 |
| MACD | -0.05 | -0.15 |
| Stochastic Oscillator | 60.24 | 25.54 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.